Journals / Turkish Journal of Medical Sciences / 2008 / Cilt: 38 - Sayı: 3

Attenuation of Vasospasm by Dexmedetomidine after Experimental Subarachnoidal Haemorrhage in Rabbits

Pages
191–197
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Our study showed that vasospasm is attenuated by dexmedetomidine administered after vasospasm is formed in a rabbit model.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Vasospasm is one of the most important factors that influence the successful treatment of ruptured intracranial aneurysm.
📊
Key Findings & Data:Materials and Methods: Experimental SAH was induced in 12 of 18 New Zealand rabbits by intracisternal injection of autologous blood.
💡
Conclusion & Impact:Conclusions: Our study showed that vasospasm is attenuated by dexmedetomidine administered after vasospasm is formed in a rabbit model.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Dexmedetomidine · subarachnoid haemorrhage · vasospasm

Abstract

Aim: Vasospasm is one of the most important factors that influence the successful treatment of ruptured intracranial aneurysm. We studied if vasospasm following subarachnoidal haemorrhage (SAH) can be alleviated by dexmedetomidine in an animal model. Materials and Methods: Experimental SAH was induced in 12 of 18 New Zealand rabbits by intracisternal injection of autologous blood. Control animals (sham SAH, n = 6) received intracisternal injection of the respective volume of physiological saline solution. Forty eight hours after the operation, rabbits in sham SAH and SAH-alone (n = 6) groups were infused intravenously with 0.9% sodium chloride for 2 h, whereas rabbits in SAH-dexmedetomidine group (n = 6) received intravenous infusion of 5 µg/kg per h dexmedetomidine for 2 h. All rabbits were sacrificed with penthotal 24 h after infusions. Basilar arteries were isolated and processed for histology. Results: The histological specimens revealed evidence of arterial narrowing and vascular wall thickening in both SAH-alone and SAH-dexmedetomidine groups. The wall thickness of basilar artery significantly increased and lumen diameter significantly reduced in SAH-alone group in comparison with basilar arteries from other groups (P < 0.05). SAH-dexmedetomidine group revealed attenuation of vasospasm formed after 72 h. Conclusions: Our study showed that vasospasm is attenuated by dexmedetomidine administered after vasospasm is formed in a rabbit model.

Özet

Aim: Vasospasm is one of the most important factors that influence the successful treatment of ruptured intracranial aneurysm. We studied if vasospasm following subarachnoidal haemorrhage (SAH) can be alleviated by dexmedetomidine in an animal model. Materials and Methods: Experimental SAH was induced in 12 of 18 New Zealand rabbits by intracisternal injection of autologous blood. Control animals (sham SAH, n = 6) received intracisternal injection of the respective volume of physiological saline solution. Forty eight hours after the operation, rabbits in sham SAH and SAH-alone (n = 6) groups were infused intravenously with 0.9% sodium chloride for 2 h, whereas rabbits in SAH-dexmedetomidine group (n = 6) received intravenous infusion of 5 µg/kg per h dexmedetomidine for 2 h. All rabbits were sacrificed with penthotal 24 h after infusions. Basilar arteries were isolated and processed for histology. Results: The histological specimens revealed evidence of arterial narrowing and vascular wall thickening in both SAH-alone and SAH-dexmedetomidine groups. The wall thickness of basilar artery significantly increased and lumen diameter significantly reduced in SAH-alone group in comparison with basilar arteries from other groups (P < 0.05). SAH-dexmedetomidine group revealed attenuation of vasospasm formed after 72 h. Conclusions: Our study showed that vasospasm is attenuated by dexmedetomidine administered after vasospasm is formed in a rabbit model.

🔖

Cite This Article

ESER, O., SONGUR, A., ELA, Y., COŞKUN, Ö., FİDAN, H., COŞAR, M. (2022). Attenuation of Vasospasm by Dexmedetomidine after Experimental Subarachnoidal Haemorrhage in Rabbits. Turkish Journal of Medical Sciences, Cilt: 38 - Sayı: 3, 191–197. https://ajindex.com/articles/611814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Wilkins RH. Attempted prevention or treatment of intracranial arterial spasm: a survey. Neurosurgery 1980; 6:198-210
  2. Atalay B, Bolay H, Dalkara T. Transcorneal stimulation of trigeminal nerve afferents to increase cerebral blood flow in rats with cerebral vasospasm: a non invasive method to activate the trigeminovascular reflex. J Neurosurg 2002; 97: 1179-1183
  3. Aydın IH, Onder A. The effect of very early cisternal irrigatio on basilar artery spasm SAH in rat model. Acta Neurochir (Wien) 1991; 113: 69-73
  4. Bagirici F, Bostanci MO. Anticonvulsive effects of nimodipine on penicillin-induced epileptiform activity. Acta Neurobiol Exp (Wars) 2006; 66 (2): 123-128
  5. Kemaloglu S, Ozkan U, Yilmaz F. Preventive effects of intracisternal alphatocopherol on cerebral vasospasm in experimental subarachnoid haemorrhage. Yonsei Med J 2003; 44: 955-960
  6. Mayberg MR, Okada T, Bark HD. The significance of morphological changes in cerebral arteries after subarachnoid haemorrhage. J Neurosug 1990; 72: 626-633
  7. Munoz-Castaneda JR, Montilla P, Padillo FJ, Bujalance I, Munoz MC, Muntane J, Tunez I. Role of serotonin in cerebral oxidative stress in rats. Acta Neurobiol Exp (Wars) 2006; 66 (1): 1-6
  8. Naredi S, Lambert G, Eden E. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000; 31: 901–906
  9. Hoffman WE, Kochs E, Werner C. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Anesthesiology 1991; 75: 328-332
  10. Maeir C, Steinberg GK, Sun GH. Neuroprotection by the α-2 adrenoceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 1993; 79: 1-7
  11. Kuhmonen J, Pokorny J, Miettinen R. Neuroprotective effects of of dexmedetomidine in the gerbil hippocampus following transient global ischemia. Anesthesiology 1997; 87: 371-377
  12. Karlsson BR, Löberg EM, Steen PA. Dexmedetomidine, a potent α2-agonist, does not affect neuronal damage following severe forebrain ischemia in the rat. Eur J Anesthesiol 1995; 12:281- 285
  13. Bunc G, Kovacic S, Strnad S. Attenuation of cerebral vasospasm in rabbits using clonidine hydrochloride, a central adrenergic agonist. Autonomic Neuroscience: Basic and Clinical 2003; 105: 71–76
  14. Matsumoto M, Zornow MH, Rabin BC, Maze M. The α–adrenergic agonist, dexmedetomidine, selectively attenuates is- 2 chemia-induced increases in striatal norepinephrine concentrations. Brain Res 1993; 627: 325–329
  15. Peerless SJ, Yasargil